GI Oncology Today: Multitarget Stool RNA Test Proves Sensitive for Colorectal Cancer, Advanced Adenomas
Erica Barnell, MD, PhD, of Washington University School of Medicine, and founder of Geneoscopy Inc, describes the multitarget stool RNA…
Geneoscopy receives Z-Code from Palmetto GBA for its Noninvasive Multi-Target Stool RNA Colorectal Cancer Screening Test
ST. LOUIS, April 12, 2023 / Geneoscopy, Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health,…
Oncology Tube Interview with Dr. David Lieberman, OHSU
Dr. David Lieberman discusses the Geneoscopy: Efficacy of Non-Invasive Colorectal Cancer Screening Test Evaluated in the CRC-PREVENT Phase 3 Trial……
Geneoscopy Receives Accreditation from the College of American Pathologists (CAP) for its St. Louis Clinical Laboratory
Adds CAP Accreditation to Clinical Laboratory Improvement Amendments (CLIA) certification
Colorectal Cancer: Screening Options and Potential Emerging Role for Pharmacists
Originally published July 1, 2022 Haytham Gareer, MD, PhD, MBA, FACS for Pharmacy Times Nearly 63% of newly diagnosed patients have advanced…